Evidence map›Paper›PMID 22461563›Full record

ArticleDevelopment (Cambridge, England)2012

p120-catenin is essential for terminal end bud function and mammary morphogenesis.

Sarah J Kurley, Brian Bierie, Robert H Carnahan, Nichole A Lobdell, Michael A Davis, Ilse Hofmann, Harold L Moses, William J Muller, Albert B Reynolds

Open access · bronzeAbstract read
In one paragraph

Article in Development (Cambridge, England), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 42 citations in OpenAlex.

  1. The dynamics of tubulogenesis in development and disease.Development (Cambridge, England) · 2025
    Review
  2. Functions of p120-catenin in physiology and diseases.Frontiers in molecular biosciences · 2024
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. p120-catenin regulates WNT signaling and EMT in the mouse embryo.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. β-Catenin haploinsufficiency promotes mammary tumorigenesis in an ErbB2-positive basal breast cancer model.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Sarah J KurleyDepartment of Cancer Biology, Vanderbilt University, Nashville, TN 37232, USA.
Brian Bierie
Robert H Carnahan
Nichole A Lobdell
Michael A Davis
Ilse Hofmann
Harold L Moses
William J Muller
Albert B Reynolds
Vanderbilt University · USVanderbilt-Ingram Cancer CenterWhitehead Institute for Biomedical Research · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
TISSUE CoreP50CA098131 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PARK, BEN HO, PIETENPOL, JENNIFER A · 2003 to 2024
$48.7M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Tyrosine Kinase-Dependant and - Independent Pathways of EGFR in Breast Cancer ProP01CA099031 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI HUNG, MIEN-CHIE · 2003 to 2014
$11.6M
TGF BETA SUPPRESSION AND PROMOTION OF MAMMARY CARCINOMASR01CA085492 · NCI · VANDERBILT UNIVERSITY · PI MOSES, HAROLD L, WEAVER, VALERIE MARIE · 2000 to 2015
$6.4M
PL20 AND CELL CELL ADHESIONR01CA055724 · NCI · VANDERBILT UNIVERSITY · PI REYNOLDS, ALBERT B · 1997 to 2010
$2.9M
A mouse model for p120 downregulation in cancerR01CA111947 · NCI · VANDERBILT UNIVERSITY · PI REYNOLDS, ALBERT B · 2005 to 2009
$1.7M
CIHR MOP 89751CIHR MOP 93525NCI NIH HHS 2P01CA099031-06A1NCI NIH HHS P01 CA099031NCI NIH HHS P30 CA068485NCI NIH HHS P30 CA68485NCI NIH HHS P50 CA098131NCI NIH HHS P50 CA98131NCI NIH HHS R01 CA055724NCI NIH HHS R01 CA085492NCI NIH HHS R01 CA111947NCI NIH HHS R01 CA55724NIDDK NIH HHS DK058404NIDDK NIH HHS P30 DK058404
6 · The paper itself

Abstract

Although p120-catenin (p120) is crucial for E-cadherin function, ablation experiments in epithelial tissues from different organ systems reveal markedly different effects. Here, we examine for the first time the consequences of p120 knockout during mouse mammary gland development. An MMTV-Cre driver was used to target knockout to the epithelium at the onset of puberty. p120 ablation was detected in approximately one-quarter of the nascent epithelium at the forth week post-partum. However, p120 null cells were essentially nonadherent, excluded from the process of terminal end bud (TEB) morphogenesis and lost altogether by week six. This elimination process caused a delay in TEB outgrowth, after which the gland developed normally from cells that had retained p120. Mechanistic studies in vitro indicate that TEB dysfunction is likely to stem from striking E-cadherin loss, failure of cell-cell adhesion and near total exclusion from the collective migration process. Our findings reveal an essential role for p120 in mammary morphogenesis.

Indexed as

AnimalsBlotting, WesternCateninsCell LineCells, CulturedDelta CateninFemaleGene Expression Regulation, DevelopmentalHumansImmunohistochemistryMammary Glands, AnimalMiceMorphogenesisWound HealingCateninsDelta Catenin

Identifiers

PMID22461563
PMCPMC3328177
OpenAlexW2077356131

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.